Case Study – Enrichment of Recombinant Therapeutic Proteins Using SCOPE™ Fractionation

Introduction Daresbury Proteins Ltd specializes in the development and manufacture of complex recombinant proteins for a range of therapeutic and research applications expressed in mammalian cell lines. Some target proteins are secreted at low levels into the cell culture medium making it challenging to purify them away from contaminants.  Entropix has developed SCOPE™, a ground-breaking […]

Case Study – Rapid Extraction of Genomic DNA from MRSA for PCR Analysis Using NADA™

Introduction Professor Simon Foster’s laboratory carries out pioneering research in the field of antibiotic resistance research. Uncovering the role of genomic elements in the resistance of Staphylococcus aureus to the penicillin class of antibiotics (MRSA) involves intensive screening of bacterial strains for alleles that promote resistance. Typically, genomic DNA is extracted from broth cultures and […]

Introducing SCOPE™: A Revolutionary Protein Fractionation Technology That Preserves Function and Complex Information

Entropix Ltd proudly announces the launch of SCOPE™ (Solvation Controlled Protein Enrichment), a groundbreaking protein fractionation technology that maintains both protein functionality and the integrity of protein complexes. SCOPE™ represents a transformative advance in proteomics, offering unprecedented insight into cellular mechanisms and disease pathways. Traditional sample preparation techniques for proteomics using mass spectrometry often compromise […]

New Bead Format of NADA™ Nucleic Acid Purification for Automated Workflows

Following the recent development of the NADA™ technology for the rapid and effective capture and recovery of nucleic acids, we are delighted to announce that Entropix has created a magnetic bead version of the technology known as MagNADA™. This magnetic bead format is designed for high throughput instruments (e.g. automated DNA sequencing workflows) and delivers […]

Case Study – Independent Validation of NADA™ technology at the University of Sheffield

Streamlining DNA Purification Without Compromising Quality: Entropix NADA™ Technology Validated at the University of Sheffield. Entropix is proud to announce that its innovative NADA™ (Nucleic Acid Depletion and Agent) technology has been successfully validated in a recent study conducted in Professor Simon Foster’s lab at the University of Sheffield. The results confirm that NADA™ delivers […]

Entropix Has Created New Technology for the Purification of Nucleic Acids

Entropix has created an exciting new technology (called NADA™) for the capture, recovery and purification of nucleic acids. NADA™ is rapid, efficient and solvent-free and delivers higher yields and purity for both DNA and RNA when compared to leading commercial kits. The company has filed a patent application covering the NADA™ technology which has numerous […]

Entropix Case Study by The Virtual Engineering Centre (VEC)

https://www.youtube.com/watch?v=kvx4_jZ4-_g “We have had a positive and successful collaboration with the VEC over the last two years. Their skills and expertise in machine learning and image analysis have enhanced our processes in Entropix and helped us to accelerate our enzyme development activities.” Rob RuleCEO, Entropix Ltd Read the full case study

Entropix Receives Investment from LYVA Labs

Entropix has recently received a six-figure investment from LYVA Labs’ Health and Life Sciences Fund to support the commercialisation of its enzyme technology and to scale development activity. LYVA Labs delivers economic growth in the Liverpool City Region through the commercialisation of innovation and by supporting the ideas, people and projects that are transforming the […]

Entropix is a Tech Climber ‘One to Watch’

Entropix is proud to announce it has been nominated by Tech Climbers in their 2024 ‘Ones to Watch’ list for the Liverpool City Region (LCR). The list shines a light on innovative, scalable and solution-led technology businesses that help make LCR one of the UK’s most exciting destinations for early-stage tech companies. Tech Climbers is […]

Entropix Welcomes Jozef Krzak to the Enzyme Development Team

Józef has first-class honours degrees in Biochemistry (BSc) and Molecular Biology and Biotechnology (MSc) from the University of Sussex and The University of Sheffield respectively. He brings specialist laboratory experience in protein expression and purification, molecular cloning, western blotting, enzymatic assays, CRISPR-Cas9 systems, chromatography, and polymerase chain reaction (PCR) techniques. Józef’s thesis focused on the […]